tldrdailynews.com logo

Could an Exercise Pill Pass Its First Human Safety Check? ENV-308

1 min read
Source: Gizmodo
Could an Exercise Pill Pass Its First Human Safety Check? ENV-308
Photo: Gizmodo
TL;DR

Enveda’s ENV-308, a pill designed to mimic the exercise-linked molecule Lac-Phe, successfully completed a Phase I trial in 88 healthy volunteers, showing safety, tolerability, and an exceptional GI safety profile. Early signs suggest it may influence leptin levels and aid weight maintenance and muscle preservation, with Phase II planned for weight-loss maintenance and exploration in migraines and inflammatory bowel disease. It’s not a substitute for real exercise, but could offer a convenient metabolic aid as development continues.

Topics:healthscience#env-308#exercise-pill#lac-phe#obesity#phase-i-trial#science
Share this article
  1. An ‘Exercise Pill’ Just Cleared Its First Human Test  Gizmodo
  2. A pill that mimics exercise? Early results on drug designed to maintain both weight loss and muscle mass  STAT
  3. Enveda Reports Positive Phase 1 Results for ENV-308, the First Pill Designed From the Chemistry of Exercise  Business Wire
  4. Enveda to move AI-discovered drug into mid-stage study for weight-loss maintenance  FirstWord Pharma
  5. Enveda’s exercise-simulating obesity tablet clears early clinical test  BioSpace

Want the full story? Read the original reporting

Read on Gizmodo